EBNA2 and c-myc in B cell immortalization by Epstein-Barr virus and in the pathogenesis of Burkitt's lymphoma.
Institut für Klinische Molekularbiologie und Tumorgenetik, GSF-Forschungszentrum für Umwelt und Gesundheit, München.
U
U
Zimber-Strobl
L
L
Strobl
H
H
Höfelmayr
B
B
Kempkes
M S
MS
Staege
G
G
Laux
B
B
Christoph
A
A
Polack
G W
GW
Bornkamm
D001402:B-Lymphocytes / Q000821:virology*; D002051:Burkitt Lymphoma / Q000209:etiology*; D002471:Cell Transformation, Neoplastic; D019309:Epstein-Barr Virus Nuclear Antigens / Q000235:genetics / Q000378:metabolism; D005814:Genes, Viral; D016259:Genes, myc; D004854:Herpesvirus 4, Human / Q000235:genetics* / Q000472:pathogenicity*; D006801:Humans; D007148:Immunoglobulin mu-Chains / Q000378:metabolism; D014407:Tumor Cells, Cultured; D014763:Viral Matrix Proteins / Q000235:genetics
C037662:EBV-associated membrane antigen, Epstein-Barr virus; D019309:Epstein-Barr Virus Nuclear Antigens; D007148:Immunoglobulin mu-Chains; D014763:Viral Matrix Proteins